MIRXES HOLDING PTE. LTD.

Last Updated: 31 Jan 2025

MIRXES HOLDING PTE. LTD. is ACRA -registered entity that has been operating for 4 years 9 months in Singapore since its incorporation in 2020.

Officially, MIRXES HOLDING PTE. LTD. is registered as Private Limited Company with its address 2 TUKANG INNOVATION GROVE, #09-02, JTC MEDTECH HUB, Singapore 618305.

Country of registration	Singapore
Registration number	202028904K
Local SIC	64202: Other holding companies
Incorporation date	20 Sep 2020
Company age	4 years 9 months
Official entity type	Private Limited Company
No. of officers	5

Contact

Address:

2 TUKANG INNOVATION GROVE, #09-02, JTC MEDTECH HUB, Singapore 618305

Phone number:

Access Key Decision Makers

This is the legal entity page of MIRXES HOLDING PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.

Associated business (1)

MIRXES
Singapore
View More
medical devices
in vitro diagnostics
agri-tech
biotech
vet-tech
contract development and manufacturing
research collaborations
early cancer detection
iso13485 manufacturing
insurtech
mirna profiling
qpcr
diagnostics
cancer
liquid biopsy
disease diagnostics
research and development
mirna
microrna
Others
MiRXES is a Singapore-headquartered biotechnology company focused on developing and commercializing innovative diagnostic solutions for early, actionable, and personalized disease detection. With a strong presence in Asia and global ambitions, we have established research, development, manufacturing, and clinical diagnostic operations in Singapore, USA, Japan, and China. Our flagship product, GASTROClear, is a molecular blood test for early detection of gastric cancer, with plans to expand our cancer portfolio to include tests for lung, thyroid, colorectal, and breast cancer. Additionally, we are developing a precision oncology portfolio to provide clinical insights for the complete patient journey. Leveraging our versatile platform technology and capabilities, we aim to address unmet clinical needs in various disease areas, including cardiovascular, metabolic, and infectious diseases. In response to COVID-19, we have leveraged our capabilities to mass produce and distribute the Fortitude COVID-19 RT-PCR test, which has been deployed in multiple hospitals and clinical labs worldwide.

This is the legal entity page of MIRXES HOLDING PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.

Financials

Auditor	KPMG LLP
Revenue	> 10m
Share Capital - Ordinary shares	SGD 1,107,728

Last updated: 31 Jan 2025

* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.

Lookalike companies

* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.

Frequently Asked Questions (FAQ)

What is the address of MIRXES HOLDING PTE. LTD.?
Where is MIRXES HOLDING PTE. LTD.'s headquarter?
What is MIRXES HOLDING PTE. LTD.'s contact number?
What MIRXES HOLDING PTE. LTD.'s spending power?
Does MIRXES HOLDING PTE. LTD. have a presence in the domain it operates in?